Virpax Pharmaceuticals Statistics
Total Valuation
VRPX has a market cap or net worth of $4.73 million. The enterprise value is -$4.41 million.
| Market Cap | 4.73M |
| Enterprise Value | -4.41M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRPX has 1.17 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Shares Outstanding | 1.17M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 25.72% |
| Owned by Institutions (%) | 3.26% |
| Float | 1.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.45 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25, with zero debt.
| Current Ratio | 1.25 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -169.00% and return on invested capital (ROIC) is -811.13%.
| Return on Equity (ROE) | -169.00% |
| Return on Assets (ROA) | -106.40% |
| Return on Capital (ROIC) | -811.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.17M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.48% in the last 52 weeks. The beta is 1.38, so VRPX's price volatility has been higher than the market average.
| Beta (1Y) | 1.38 |
| 52-Week Price Change | -47.48% |
| 50-Day Moving Average | 3.76 |
| 200-Day Moving Average | 5.94 |
| Relative Strength Index (RSI) | 55.03 |
| Average Volume (30 Days) | 24,094 |
Short Selling Information
The latest short interest is 29,830, so 2.55% of the outstanding shares have been sold short.
| Short Interest | 29,830 |
| Short Previous Month | 23,857 |
| Short % of Shares Out | 2.55% |
| Short % of Float | 2.61% |
| Short Ratio (days to cover) | 0.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.69M |
| Pretax Income | -15.19M |
| Net Income | -15.19M |
| EBITDA | -15.19M |
| EBIT | -15.19M |
| Earnings Per Share (EPS) | -$12.97 |
Balance Sheet
The company has $9.14 million in cash and no debt, giving a net cash position of $9.14 million or $7.81 per share.
| Cash & Cash Equivalents | 9.14M |
| Total Debt | n/a |
| Net Cash | 9.14M |
| Net Cash Per Share | $7.81 |
| Equity / Book Value | 1.93M |
| Book Value Per Share | 1.65 |
| Working Capital | 1.93M |
Cash Flow
| Operating Cash Flow | -9.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.85M |
| FCF Per Share | -$8.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRPX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | -321.01% |
| FCF Yield | -208.25% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Mar 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |